Q1 2024 --06-30 false 0000812306 0 4,792 0 1 0 0.10 0 0 0 0 0 0 00008123062023-07-012023-09-30 xbrli:pure 00008123062023-09-30 utr:Y iso4217:USD 00008123062022-07-012022-09-30 00008123062022-07-012023-09-30 00008123062022-06-30 0000812306pcyn:OperatingLeaseForOfficeSpaceMember2021-01-31 0000812306pcyn:OperatingLeaseForOfficeSpaceMember2021-01-012021-01-31 utr:M 0000812306pcyn:OperatingLeaseForWarehouseMember2021-01-31 0000812306pcyn:OperatingLeaseForWarehouseMember2021-01-012021-01-31 0000812306pcyn:OperatingLeaseForOfficeEquipmentMember2021-05-31 0000812306pcyn:OperatingLeaseForOfficeEquipmentMember2021-05-012021-05-31 0000812306pcyn:OperatingLeaseForOfficeEquipmentMember2020-08-31 0000812306pcyn:OperatingLeaseForOfficeEquipmentMember2020-08-012020-08-31 0000812306pcyn:OperatingLeaseForOfficeEquipmentMember2015-06-30 00008123062021-07-012022-06-30 00008123062021-06-30 iso4217:USDxbrli:shares xbrli:shares 0000812306us-gaap:ConvertiblePreferredStockMember2023-07-012023-09-30 0000812306srt:MinimumMember2023-09-30 0000812306srt:MinimumMember2023-07-012023-09-30 0000812306us-gaap:ConvertiblePreferredStockMember2023-09-30 0000812306us-gaap:ConvertiblePreferredStockMember2095-01-012095-01-31 0000812306us-gaap:ConvertiblePreferredStockMember2095-01-31 00008123062023-06-30 00008123062022-09-30 00008123062021-09-30 0000812306pcyn:The2020OptionPlanMember2023-09-30 0000812306pcyn:The2009OptionPlanMember2023-09-30 0000812306us-gaap:RetainedEarningsMember2022-09-30 0000812306us-gaap:AdditionalPaidInCapitalMember2022-09-30 0000812306us-gaap:CommonStockMember2022-09-30 0000812306us-gaap:ConvertiblePreferredStockMemberus-gaap:PreferredStockMember2022-09-30 0000812306us-gaap:RetainedEarningsMember2022-07-012022-09-30 0000812306us-gaap:AdditionalPaidInCapitalMember2022-07-012022-09-30 0000812306us-gaap:CommonStockMember2022-07-012022-09-30 0000812306us-gaap:ConvertiblePreferredStockMemberus-gaap:PreferredStockMember2022-07-012022-09-30 0000812306us-gaap:RetainedEarningsMember2022-06-30 0000812306us-gaap:AdditionalPaidInCapitalMember2022-06-30 0000812306us-gaap:CommonStockMember2022-06-30 0000812306us-gaap:ConvertiblePreferredStockMemberus-gaap:PreferredStockMember2022-06-30 0000812306us-gaap:RetainedEarningsMember2023-09-30 0000812306us-gaap:AdditionalPaidInCapitalMember2023-09-30 0000812306us-gaap:CommonStockMember2023-09-30 0000812306us-gaap:ConvertiblePreferredStockMemberus-gaap:PreferredStockMember2023-09-30 0000812306us-gaap:RetainedEarningsMember2023-07-012023-09-30 0000812306us-gaap:AdditionalPaidInCapitalMember2023-07-012023-09-30 0000812306us-gaap:CommonStockMember2023-07-012023-09-30 0000812306us-gaap:ConvertiblePreferredStockMemberus-gaap:PreferredStockMember2023-07-012023-09-30 0000812306us-gaap:RetainedEarningsMember2023-06-30 0000812306us-gaap:AdditionalPaidInCapitalMember2023-06-30 0000812306us-gaap:CommonStockMember2023-06-30 0000812306us-gaap:ConvertiblePreferredStockMemberus-gaap:PreferredStockMember2023-06-30 0000812306us-gaap:ConvertiblePreferredStockMember2023-06-30 00008123062023-11-14 thunderdome:item
 

 

UNITED STATES SECURITIES & EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

  For Quarterly Period Ended September 30, 2023

or

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

  For the transition period from         to

 

Commission File Number: 0-17449

 

PROCYON CORPORATION

(Exact Name of Registrant as specified in its charter)

 

Colorado 59-3280822
(State of Incorporation)  (I.R.S. Employer Identification Number)

 

164 Douglas Road East, Oldsmar, FL 34677

(Address of Principal Executive Offices)

 

(727) 447-2998

(Registrant’s Telephone Number, Including Area Code)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

None

None

None

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ NO ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

Yes ☒ NO ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and “emerging growth company” in Rule 12b-2 of the Exchange Act.

  Large accelerated filer ☐ Accelerated filer ☐
  Non-accelerated filer Smaller reporting company
  Emerging growth company  

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). YES  NO ☒

 

Indicate the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practicable date: Common stock, no par value; 8,108,388 shares outstanding as of November 14, 2023.

 

 

 

 

PART I. - FINANCIAL INFORMATION

 

Item   Page
     
ITEM 1. FINANCIAL STATEMENTS 3
     
Index to Financial Statements  
     
Financial Statements:  
     
Consolidated Balance Sheets 3
Consolidated Statements of Operations 4
Consolidated Statements of Changes in Stockholders’ Equity 5
Consolidated Statements of Cash Flows 6
     
Notes to Consolidated Financial Statements  7
     
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 13
     
ITEM 4. CONTROLS AND PROCEDURES 16
     
PART II. - OTHER INFORMATION
     
ITEM 5. OTHER INFORMATION 17
     
ITEM 6. EXHIBITS 18
     
SIGNATURES 18

 

 

 

 

 

PROCYON CORPORATION & SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

September 30, 2023 and June 30, 2023

 

   

(unaudited)

   

(audited)

 

 

 

September 30,

   

June 30,

 
   

2023

   

2023

 
ASSETS                
                 

CURRENT ASSETS

               

Cash

  $ 402,486     $ 451,306  

Certificates of Deposit, plus accrued interest

    566,602       562,472  

Accounts Receivable, less allowance for credit losses of $18,370 and $11,625 respectively.

    434,266       493,953  

Inventories

    544,267       431,405  

Prepaid Expenses

    215,724       298,469  

TOTAL CURRENT ASSETS

    2,163,345       2,237,605  
                 

PROPERTY AND EQUIPMENT, NET

    315,273       281,023  
                 

OTHER ASSETS

               

Deposits

    4,665       9,220  

Inventories

    287,061       330,513  

Intangible Asset

    17,000       17,000  

ROU Assets - Operating Leases

    480,484       527,170  

Deferred Tax Asset, Net of Valuation Allowance of $0 and $0, respectively

    170,550       161,180  
      959,760       1,045,083  
                 

TOTAL ASSETS

  $ 3,438,378     $ 3,563,711  
                 

LIABILITIES AND STOCKHOLDERS' EQUITY

               
                 

CURRENT LIABILITIES

               

Accounts Payable

  $ 172,172     $ 175,057  

Accrued Expenses

    220,904       277,498  

Lease Liability

    175,317       173,565  

TOTAL CURRENT LIABILITIES

    568,393       626,120  
                 

LONG TERM LIABILITIES

               

Lease Liability

    275,410       319,882  

TOTAL LONG TERM LIABILITIES

    275,410       319,882  
                 

TOTAL LIABILITIES

    843,803       946,002  
                 

COMMITMENTS AND CONTINGENCIES

           
                 

STOCKHOLDERS' EQUITY

               

Preferred Stock, 496,000,000 shares authorized, none issued.

    -       -  

Series A Cumulative Convertible Preferred Stock, no par value; 4,000,000 shares authorized; 166,900 and 167,100 shares issued and  outstanding, respectively.

    126,660       126,860  

Common Stock, no par value, 80,000,000 shares authorized; 8,108,388 and 8,087,388 shares issued and outstanding, repsectively.

    4,450,166       4,444,766  

Paid-in Capital

    41,085       35,564  

Accumulated Deficit

    (2,023,336 )     (1,989,481 )

TOTAL STOCKHOLDERS' EQUITY

    2,594,575       2,617,709  
                 

TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY

  $ 3,438,378     $ 3,563,711  

 

The accompanying notes are an integral part of these financial statements.

 

-3-

 

 

PROCYON CORPORATION & SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS

Three Months Ended September 30, 2023 and 2022

 

   

(unaudited)

   

(unaudited)

 
   

Three Months

   

Three Months

 
   

Ended

   

Ended

 
   

Sep. 30, 2023

   

Sep. 30 2022

 
                 

NET SALES

  $ 1,173,107     $ 1,175,703  
                 

COST OF SALES

    260,705       294,904  
                 

GROSS PROFIT

    912,402       880,799  
                 

OPERATING EXPENSES

               

Salaries and Benefits

    478,026       468,157  

Selling, General and Administrative

    491,767       424,095  
      969,793       892,252  
                 

INCOME FROM OPERATIONS

    (57,391 )     (11,453 )
                 
OTHER INCOME                

Rental Income

    8,958       -  

Interest Income

    5,208       895  
      14,166       895  
                 

INCOME BEFORE INCOME TAXES

    (43,225 )     (10,558 )
                 

INCOME TAX (BENEFIT/EXPENSE)

    9,370       2,371  
                 

NET INCOME

    (33,855 )     (8,187 )
                 

Dividend requirements on preferred stock

    (3,633 )     (4,177 )
                 

Basic net income available to common shares

  $ (37,488 )   $ (12,364 )
                 

Basic net income per common share

  $ (0.01 )   $ (0.00 )
                 

Weighted average number of common shares outstanding

    8,108,388       8,087,388  
                 

Diluted net income per common share

  $ (0.01 )   $ (0.00 )
                 

Weighted average number of common shares outstanding, diluted

    8,108,388       8,087,388  

 

The accompanying notes are an integral part of these financial statements.

 

-4-

 

 

PROCYON CORPORATION & SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY

For the Three Months Ended September 30, 2023 and 2022

 

                                                   

Total

 

Three Months Ended September 30, 2023

 

Preferred Stock

   

Common Stock

   

Paid-In

   

Accumulated

   

Stockholders'

 
   

Shares

   

Amount

   

Shares

   

Amount

   

Capital

   

Deficit

   

Equtiy

 

Balance, June 30, 2023

    167,100     $ 126,860       8,087,388     $ 4,444,766     $ 35,564     $ (1,989,481 )   $ 2,617,709  
                                                         

Stock Based Compensation

    -       -       20,800       5,200       5,521       -       10,721  
                                                         

Preferred Stock Converted to Common

    (200 )     (200 )     200       200       -       -       -  
                                                         

Net Income

    -       -       -       -       -       (33,855 )     (33,855 )
                                                         

Balance, September 30, 2023

    166,900     $ 126,660       8,108,388     $ 4,450,166     $ 41,085     $ (2,023,336 )   $ 2,594,575  

 

Three Months Ended September 30, 2022

 

Preferred Stock

   

Common Stock

   

Paid-In

   

Accumulated

   

Total

Stockholders'

 
   

Shares

   

Amount

   

Shares

   

Amount

   

Capital

   

Deficit

   

Equtiy

 

Balance, June 30, 2022 (As restated)

    167,100     $ 126,860       8,087,388     $ 4,444,766     $ 35,564     $ (1,939,236 )   $ 2,667,954  
                                                         

Net Income

    -       -       -       -       -       (8,187 )     (8,187 )
                                                         

Balance, September 30, 2022

    167,100     $ 126,860       8,087,388     $ 4,444,766     $ 35,564     $ (1,947,423 )   $ 2,659,767  

 

The accompanying notes are an integral part of these financial statements.

 

-5-

 

 

PROCYON CORPORATION & SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

For the Three Months Ending September 30, 2023 and 2022

 

   

(unaudited)

   

(unaudited)

 
   

September 30,

   

September 30,

 
   

2023

   

2022

 
                 

CASH FLOWS FROM OPERATING ACTIVITIES

               
                 

Net (Loss)

  $ (33,855 )   $ (8,187 )

Adjustments to reconcile net income to net cash provided by operating activities:

         

Depreciation

    19,154       10,913  

Increase in Allowance for Doubtfull Accounts

    6,745       -  

Right of Use Asset Amortization

    46,686       44,836  

Accrued Interest on Certificates of Deposit

    (4,130 )     (173 )

Deferred Income Taxes

    (9,370 )     29,589  

Valuation Allowance

    -       (31,960 )

Stock Based Compensation

    10,721       -  
(Increase) Decrease in:                

Accounts Receivable

    52,942       (120,077 )

Deposits

    4,555       1,445  

Inventory

    (69,410 )     (13,143 )

Prepaid Expenses

    82,745       125,737  
                 
(Decrease) Increase in:                

Accounts Payable

    (2,885 )     (63,161 )

Accrued Expenses

    (56,593 )     (104,714 )

Payments on operating lease liability

    (42,720 )     (40,003 )

NET CASH (USED IN) / PROVIDED BY OPERATING ACTIVITIES

    4,585       (168,898 )
                 

CASH FLOW FROM INVESTING ACTIVITIES

               
                 

Purchase of property & equipment

    (53,405 )     (7,003 )

NET CASH (USED IN) INVESTING ACTIVITIES

    (53,405 )     (7,003 )
                 

CASH FLOW FROM FINANCING ACTIVITIES

               
                 

NET CASH PROVIDED BY /(USED IN) FINANCING ACTIVITIES

    -       -  
                 

NET CHANGE IN CASH

    (48,820 )     (175,901 )
                 

CASH AT BEGINNING OF PERIOD

    451,306       760,396  
                 

CASH AT END OF PERIOD

  $ 402,486     $ 584,495  
                 

SUPPLEMENTAL DISCLOSURES

               
                 

Interest Paid

  $ -     $ -  

Taxes Paid

  $ -     $ -  
                 

NONCASH DISCLOSURE

               

 

During the quarter ended September 30, 2023, we increased a Right of Use Asset and corresponding lease liability in the amount of $34,798

 

During the quarter ended September 30, 2023, 200 shares of Series A Cumulative Convertible Preferred Stock converted in the amount of $200

 

The accompanying notes are an integral part of these financial statements.

 

-6-

 

Notes to Financial Statements

 

 

NOTE A - SUMMARY OF ACCOUNTING POLICIES

 

The interim consolidated financial statements included herein have been prepared by the Company without audit, pursuant to the rules and regulations of the Securities and Exchange Commission. Certain information and footnote disclosures normally included in the financial statements prepared in accordance with generally accepted accounting principles ("GAAP") have been condensed or omitted as allowed by such rules and regulations. The Company believes that the disclosures are adequate to make the information presented not misleading. These consolidated financial statements should be read in conjunction with the Company's audited consolidated financial statements dated June 30, 2023. The results for interim periods are not necessarily indicative of results that may be expected for any other interim period or for the full year.

 

Management of the Company has prepared the accompanying unaudited condensed consolidated financial statements prepared in conformity with generally accepted accounting principles, which require the use of management estimates, contain all adjustments (including normal recurring adjustments) necessary to present fairly the operations and cash flows for the period presented and to make the financial statements not misleading.

 

STOCK-BASED COMPENSATION

 

Stock based compensation is accounted for in accordance with Topic 718 - Compensation - Stock Compensation in the Accounting Standards Codification. Pursuant to Topic 718, all share-based payments to employees, including grants of employee stock options, are to be recognized in the statement of operations based upon their fair values. Topic 718 rescinds the acceptance of pro forma disclosure. In December 2009, our shareholders approved the adoption of a new stock option plan, providing the Company a continued means of offering stock-based compensation.

 

On September 30, 2023, there were 65,000 outstanding options to purchase shares of our common stock granted under our prior 2009 Stock Option Plan. There were 50,000 outstanding options to purchase shares of our common stock granted under our 2020 Stock Option Plan.

 

The fair value of a stock option is determined using the Black-Scholes option-pricing model, which values options based on the stock price at the grant date, the expected life of the option, the estimated volatility of the stock, the expected dividend payments, and the risk-free interest rate over the life of the option. There were 25,432 options granted during the quarter ended September 30, 2023.

 

The Black-Scholes option valuation model was developed for estimating the fair value of traded options that have no vesting restrictions and are fully transferable. Because option valuation models require the use of subjective assumptions, changes in these assumptions can materially affect the fair value of the options. Our options do not have the characteristics of traded options, therefore, the option valuation models do not necessarily provide a reliable measure of the fair value of our options.

 

-7-

 

Additional information with respect to stock option activity is as follows:

 

 

 

 

Number of

Shares

   

Weighted Average

Exercise Price

 

Outstanding at September 30, 2021

    115,00     $ 0.17  
Granted     -     $    
Exercised     -     $    
Cancelled     -     $    

Outstanding at September 30, 2022

    115,000     $ 0.17  
Granted     25,432     $ 0.25  
Exercised     -    

$

-  
Cancelled     -     $ -  

Outstanding at September 30, 2023

    140,432     $ 0.26  

Options exercisable at September 30, 2022

    115,000     $ 0.17  

Options exercisable at September 30, 2023

    140,432     $ 0.25  

 

EARNINGS PER SHARE

 

Basic earnings per share (EPS) is computed by dividing income available to common stockholders by the weighted-average number of common shares outstanding for the period. Diluted EPS reflects the potential dilution that would occur if dilutive securities such as stock options and other contracts to issue Common Stock were exercised or converted into Common Stock or resulted in the issuance of Common Stock that then shared in earnings. We use the treasury stock method to compute potential common shares from stock options and the as-if-converted method to compute potential common shares from Preferred Stock.

 

For the three months ended September 30, 2023, the potential dilutive effects of the preferred stock and stock options were excluded in the weighted-average shares outstanding, as the shares would have an anti-dilutive effect on the loss from operations.

 

For the three months ended September 30, 2022, the potential dilutive effects of the preferred stock and stock options were excluded in the weighted-average shares outstanding, as the shares would have an anti-dilutive effect on the loss from operations.

 

-8-

 

 

NOTE B - INVENTORIES

 

 

Inventories consisted of the following:

 

  September 30,

2023

   

June 30,

2023

 
                 

Finished Goods

  $ 616,717     $ 576,548  

Raw Materials

    214,611       185,370  
    $ 831,328     $ 761,918  

 

At September 30, 2023 and June 30, 2023, respectively, $287,061 and $330,513 of our inventory was considered non-current as it will not be used within a one year period.

 

 

NOTE C - STOCKHOLDERS' EQUITY

 

During January 1995, the Company's Board of Directors authorized the issuance of up to 4,000,000 shares of Series A Cumulative Convertible Preferred Stock ("Series A Preferred Stock"). The preferred stockholders are entitled to receive, as and if declared by the board of directors, quarterly dividends at an annual rate of $.10 per share of Series A Preferred Stock per annum. Dividends will accrue without interest and will be cumulative from the date of issuance of the Series A Preferred Stock and will be payable quarterly in arrears in cash or publicly traded common stock when and if declared by the Board of Directors. As of September 30, 2023, no dividends have been declared. Dividends in arrears on the outstanding preferred shares total $441,569 as of September 30, 2023.

 

Holders of the Preferred Stock have the right to convert their shares of Preferred Stock into an equal number of shares of Common Stock of the Company. In addition, Preferred Stock holders have the right to vote the number of shares into which their shares are convertible into Common Stock. Such preferred shares will automatically convert into one share of Common Stock at the close of a public offering of Common Stock by the Company provided the Company receives gross proceeds of at least $1,000,000, and the initial offering price of the Common Stock sold in such offering is equal to or in excess of $1 per share. The Company is obligated to reserve an adequate number of shares of its common stock to satisfy the conversion of all the outstanding Series A Preferred Stock. There were 200 shares converted during the reporting period. So long as any share of Series A Preferred Stock is outstanding, the Company is prohibited from declaring dividends or other distributions related to its Common Stock or purchasing, redeeming or otherwise acquiring any of the Common Stock.

 

Share-based compensation expense recognized during the period is based on the value of the portion of share-based payment awards that is ultimately expected to vest. As share-based compensation expense recognized in the statement of operations is based on awards ultimately expected to vest, it can be reduced for estimated forfeitures. The ASC topic Stock Compensation requires forfeitures to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. The share based compensation charged against income for the periods ended September 30, 2023 and 2022 was $0 and $0 respectively.

 

-9-

 

 

The Black-Scholes option-pricing model, which values options based on the stock price at grant date, the expected life of the options, the estimated volatility of the stock and the risk free interest rate over the life of the option. The assumption used in the Black-Scholes model were as follows for the stock options granted in July 2023.

 

Stock Price at Date of Grant

  $ .248  

Risk-free interest rate

    3.97 %

Expected volatility of common stock

    90.37 %

Dividend yield

    0 %

Expected life of options (in years)

    10  

 

 

NOTE D - INCOME TAXES AND AVAILABLE CARRYFORWARD

 

As of September 30, 2023, the Company had consolidated income tax net operating loss ("NOL") carryforwards for federal income tax purposes of approximately $787,000. NOL arising before December 31, 2020 will expire in various years ending through the year 2035 and for losses arising in taxable years beginning after December 31, 2020, the deduction is limited to 80% of taxable income and can be carried forward indefinitely. The utilization of certain loss carryforwards are limited under Section 382 of the Internal Revenue Code.

 

The components of the provision for income tax (expense) attributable to continuing operations are as follows:

 

   

Three Months

   

Three Months

 
   

September 30, 2023

   

September 30, 2022

 
Current                

Federal

  $ 0     $ 0  

State

    0       0  
    $       $    

Deferred

               

Federal

  $ 7,764     $ 1,965  

State

    1,606       406  
    $ 9,370     $ 2,371  
                 

Total Income Tax Benefit / (Expense)

  $ 9,370     $ 2,371  

 

-10-

 

 

Deferred income taxes reflect the net tax effects of the temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of the Company's deferred tax assets and liabilities are as follows:

 

   

Non-Current

 

Deferred tax assets

       

NOL and contribution carryforwards

  $ 199,540  

Share based payments

    6,387  

Lease liabilities - operating leases

    114,237  

Accrued compensated absences

    10,271  

Accrued bonus

    1,465  

Allowance for doubtful accounts

    5,486  

Total deferred tax assets

    337,386  
         
Deferred tax (liabilities)        

Right-of-use-assets - operating leases

    (121,779 )

Excess of tax over book depreciation

    (45,057 )

Total deferred tax (liabilities)

    (166,836 )
         

Total deferred tax asset

    170,550  

Valuation Allowance

    -  

Net Deferred Tax Asset

  $ 170,550  
         
The change in the valuation allowance is as follows:        
June 30, 2023   $ 0  
September 30, 2023   $ -  
    $ 0  

 

Income taxes for the three months ended September 30, 2023 and 2022 differ from the amounts computed by applying the effective income tax rate of 25.35%, to income before income taxes as a result of the following:

 

   

Three Months

   

Three Months

 
   

September 30, 2023

   

September 30, 2022

 

Expected (provision) at US statutory rate

  $ 9,077     $ 2,217  

State income tax net of federal (provision)

    1,878       459  

Nondeductible Expense

    (1,539 )     (305 )

Change in estimates of loss carryforward

    (46 )     (31,960 )

Change in valuation allowance

    -     $ 31,960  

Income Tax (Expense)

  $ 9,370     $ 2,371  

 

-11-

 

The earliest tax year still subject to examination by a major taxing jurisdiction is fiscal year end June 30, 2021.

 

The Company performed a review of its uncertain tax positions in accordance with Accounting Standards Codification ASC 740-10 "Uncertainty in Income Taxes". In this regard, an uncertain tax position represents the Company's expected treatment of a tax position taken in a filed tax return, or planned to be taken in a future tax return, that has not been reflected in measuring income tax expense for financial reporting purposes.

 

 

NOTE E - LINE OF CREDIT

 

A line of credit was procured in June 2021, with a bank. The limit for this line of credit is $250,000. Terms of the line of credit include an interest rate that fluctuates based on prime plus a half of point, with monthly interest only payments. The line of credit renews annually on June 30th. This line of credit renews annually until either party decides otherwise. At September 30, 2023, the Company had drawn and owed $0 on the line of credit.

 

Interest expense for the year ended June 30, 2023 and the period ending September 30, 2023, was $0 and $0, respectively.

 

The line of credit is guaranteed by Justice W. Anderson, President and Chief Executive Officer.

 

 

NOTE F - RECENT ACCOUNTING PRONOUNCEMENTS

 

Adoption of new accounting standards

 

New accounting standards or accounting standards updates were assessed and determined to be either not applicable or not having a material impact on the Company’s consolidated financial statements or processes.

 

 

NOTE G - RIGHT-OF-USE ASSETS AND LEASE LIABILITIES

 

Operating leases

 

In August 2020, the Company entered into a lease agreement to lease certain office equipment with a lease term of 63 months. The lease renews on a month-to-month basis and contains an option to purchase the equipment at fair market value or return the equipment. Historically, the Company has not exercised the option to purchase at the end of the initial lease term for similar leases and simply returned the equipment at the end of the initial lease term. Initial rent amount was $574 per month. In applying ASC 842, the Company uses a lease term of 63 months and an incremental borrowing rate of 4.25% which was the borrowing rate on the Company’s line of credit with a financial institution.

 

In May 2021, the Company entered into a lease agreement to lease certain office equipment with a lease term of 39 months. The lease expires at the end of the lease term and the Company can simply return the equipment at the end of the initial lease term or upgrade the equipment during or at the end of the current lease term. Initial rent amount was $547 per month. In applying ASC 842, the Company uses a lease term of 39 months and an incremental borrowing rate of 4.25% which was the borrowing rate on the Company’s line of credit with a financial institution.

 

-12-

 

 

In January 2021, the Company entered in a lease agreement to lease warehouse space with a lease term of 64 months. The Company pays no rent for the first four months of the lease and pays $4,792.50 per month beginning the 5th month of the lease. Rent will increase each succeeding year by no less than 2% but not more than 5%. The rent amount includes common area maintenance charges which are considered nonlease components. In applying ASC 842, the Company is electing to account for nonlease components as being related to the lease component. In addition, the Company uses a lease term of 64 months and an incremental borrowing rate at prime rate of 3.25% which was the borrowing rate on the Company’s recent line of credit with a financial institution.

 

In January 2021, the Company entered in a lease agreement to lease office space with a lease term of 64 months. The Company paid no rent for the first four months of the lease and pays $9,372 per month beginning the 5th month of the lease. Rent will increase each succeeding year by no less than 2% but not more than 5%. The rent amount includes common area maintenance charges which are considered nonlease components. In applying ASC 842, the Company is electing to account for nonlease components as being related to the lease component. The Company also incurred initial direct cost of $114,083 related to existing improvements in the leased space. This initial direct cost has been included in determining the initial ROU asset and liability amounts. In addition, the Company uses a lease term of 64 months and an incremental borrowing rate at prime rate of 3.25% which was the borrowing rate on the Company’s recent line of credit with a financial institution.

 

The following is information related to the Company’s right-of-use assets and liabilities for its operating leases:

 

ROU assets - operating leases obtained in exchange for lease liabilities - operating leases   $ 979,744  
Amortization of ROU assets since lease inception   $ (499,260 )

ROU assets - operating leases at September 30, 2023

  $ 480,484  
         

Lease liabilities - operating leases on adoption date and increase in lease liabilities

  $ 979,744  

Payments on lease liabilities

    (529,017 )

Lease liabilities - operating leases on September 30, 2023

    450,727  

Lease liabilities - operating leases due in the 12 months ending September 30, 2024

    175,317  

Lease liabilities - operating leases due after September 30, 2024

  $ 275,410  

 

Variable lease expense was $50,567 and $50,020 for the three months ended September 30, 2023 and 2022, respectively.

 

Weighted average remaining lease term was 2.48 years and weighted average discount rate was 3.29% at September 30, 2023.

 

 

NOTE H - SUBSEQUENT EVENTS

 

We have evaluated subsequent events through November 15, 2023, which is the date the financial statements were available to be issued.

 

-13-

 

 

 

ITEM 2.          MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

 

General

 

You should read the following discussion and analysis in conjunction with the unaudited Condensed Financial Statements and Notes thereto appearing elsewhere in this report.

 

This Report on Form 10-Q, including Management's Discussion and Analysis of Financial Condition and Results of Operations, contains forward-looking statements. When used in this report, the words "may," "will," "expect," "anticipate," "continue," "estimate," "project," "intend," "hope," "believe" and similar expressions, variations of these words or the negative of those words, and, any statement regarding possible or assumed future results of operations of the Company's business, the markets for its products, anticipated expenditures, regulatory developments or competition, or other statements regarding matters that are not historical facts, are intended to identify forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 regarding events, conditions and financial trends including, without limitation, business conditions in the skin and wound care market and the general economy, competitive factors, changes in product mix, production delays, product recalls, manufacturing capabilities, the loss of any significant customers or suppliers, general supply chain delays, the cost of rising inflation, cyber security breaches, natural disaster impacts, the impact of the COVID-19 pandemic on the Company’s sales, operations and supply chain and other risks or uncertainties detailed in other of the Company's Securities and Exchange Commission filings. Such statements are based on management's current expectations and are subject to risks, uncertainties and assumptions. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, the Company's actual plan of operations, business strategy, operating results and financial position could differ materially from those expressed in, or implied by, such forward-looking statements.

 

Recent Developments

 

In fiscal 2024 to date, management has expanded on the services and options the Company provides for its customers. We have introduced a new Rolled Gauze form of our Amerx Branded Collagen Wound Care Kits. We also introduced a gel form of our Collagen products.

 

CRITICAL ACCOUNTING POLICIES AND ESTIMATES

 

The Company's condensed consolidated financial statements have been prepared in accordance with standards of the Public Company Accounting Oversight Board (United States), which require the Company to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and the related disclosures. A summary of those significant accounting policies can be found in the Notes to the Consolidated Financial Statements included in the Company's annual report on form 10-K, for the year ended June 30, 2023, which was filed with the Securities and Exchange Commission on September 28, 2023. The estimates used by management are based upon the Company's historical experiences combined with management's understanding of current facts and circumstances. Certain of the Company's accounting policies are considered critical as they are both important to the portrayal of the Company's financial condition and the results of its operations and require significant or complex judgments on the part of management. We believe that the following critical accounting policies affect the more significant judgments and estimates used in the preparation of our consolidated financial statements.

 

-14-

 

 

Accounts Receivable Allowance

 

Accounts receivable allowance reflects a reserve that reduces our customer accounts and receivable to the net amount estimated to be collectible. The valuation of accounts receivable is based upon the credit-worthiness of customers and third-party payers as well as historical collection experience. Allowances for doubtful accounts are recorded as a selling, general and administrative expense for estimated amounts expected to be uncollectible from third-party payers and customers. The Company bases its estimates on its historical collection experience, current trends, credit policy and on the analysis of accounts by aging category. At September 30, 2023, and June 30, 2023, our allowance for doubtful accounts totaled $18,370 and $11,625, respectively.

 

Advertising and Marketing

 

The Company uses several forms of advertising, including sponsorships to agencies who represent the professionals in their respective fields. The Company expenses these sponsorships over the term of the advertising arrangements on a straight line basis. Other forms of advertising used by the Company include professional journal advertisements, distributor catalogs, website and mailing campaigns. These forms of advertising are expensed when incurred.

 

Deferred Income Taxes

 

Deferred income taxes are recognized for the expected tax consequences in future years for differences between the tax bases of assets and liabilities and their financial reporting amounts, based upon enacted tax laws and statutory tax rates applicable to the periods in which the differences are expected to affect taxable income. The Company accounts for income taxes under Topic 740 - Income Tax in the Accounting Standards Codification. A valuation allowance is used to reduce deferred tax assets to the net amount expected to be recovered in future periods. The estimates for deferred tax assets and the corresponding valuation allowance require us to exercise complex judgments. We periodically review and adjust those estimates based upon the most current information available. The Company had a valuation allowance of $0 as of September 30, 2023 and $0 as of June 30, 2023, respectively. Because the recoverability of deferred tax assets is directly dependent upon future operating results, actual recoverability of deferred tax assets may differ materially from our estimates.

 

Revenue Recognition

 

The Company recognizes revenue in accordance with the Financial Accounting Standards Board's (FASB) release of Accounting Standards Update (ASU) 2014-09, Revenue from Contracts with Customers (Topic 606) which requires that five basic criteria must be met before revenue can be recognized: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract, and (5) recognize revenue when (or as) the entity satisfies a performance obligation.

 

Stock Based Compensation

 

Stock based compensation is accounted for in accordance with Topic 718 - Compensation - Stock Compensation in the Accounting Standards Codification. All share-based payments to employees, including grants of employee stock options, are to be recognized in the statement of operations based upon their fair values. Topic 718 rescinds the acceptance of pro forma disclosure.

 

-15-

 

 

FINANCIAL CONDITION

 

As of September 30, 2023 the Company's principal sources of liquid assets included cash of $402,486, inventories of $544,267, and net accounts receivable of $434,266. The Company also has $566,602 in Certificate of Deposits. The Company had net working capital of $1,594,952, and long-term lease of $275,410, at September 30, 2023.

 

During the three months ended September 30, 2023 cash decreased from $451,306 as of June 30, 2023, to $402,486. Operating activities provided cash of $4,585 during the period. Investing and Financing activities used cash of $53,405 and $0, respectively during the period.

 

The Company reflected a net non-current deferred tax asset of $170,550, at September 30, 2023. Because the recoverability of deferred tax assets is directly dependent upon future operating results, actual recoverability of deferred tax assets may differ materially from our estimates.

 

RESULTS OF OPERATIONS

 

Comparison of the three months ended September 30, 2023 and 2022.

 

Net sales during the quarter ended September 30, 2023, were $1,173,107 as compared to the previous year's quarter net sales of $1,175,703, a decrease of $2,596, or less then 1%.

 

Gross profit during the quarter ended September 30, 2023, was $912,402 as compared to $880,799 during the quarter ended September 30, 2022, an increase of $31,603 or 4%. As a percentage of net sales, gross profit was approximately 78% in the quarter ended September 30, 2023, and approximately 75% in the corresponding quarter in 2022. We believe that the change in Gross Profit comes from a shift in sales channels to more sales coming from our highest margin channel of sales.

 

Operating expenses during the quarter ended September 30, 2023 were $969,793, consisting of $478,026 in salaries and benefits and $491,767 in selling, general and administrative expenses. This compares to operating expenses during the quarter ended September 30, 2022 of $892,252, consisting of $468,157 in salaries and benefits; and $424,095 in selling, general and administrative expenses. Expenses for the quarter ended September 30, 2023, increased by $77,541 or approximately 9% compared to the corresponding quarter in 2022. Salaries and Benefits increased as a result of increased salaries driven by the current economies of the available workforce. Operating expenses increased primarily due to increases in marketing expenses, channel fees and shipping cost.

 

Operating profit decreased by $45,938 to an operating loss of $57,391 for the quarter ended September 30, 2023, as compared to an operating loss of $11,453 in the comparable quarter of the prior year. The decrease in net income for the three month period, of the comparable quarter of the prior year before income taxes was primarily attributable to the increases in marketing expenses, channel fees, shipping cost and increases in wages to meet market demand.

 

ITEM 4. CONTROLS AND PROCEDURES

 

(a) Evaluation of Disclosure Controls and Procedures

 

Management of the Company, with the participation of the Chief Executive Officer and Chief Financial Officer, has conducted an evaluation of the effectiveness of the Company's disclosure controls and procedures pursuant to Rule 13a-15 under the Securities Exchange Act of 1934 as of the end of the period covered by this report. Based on that evaluation, management, including the Chief Executive and Chief Financial Officer, has concluded that, as of the end of the period covered by this report, the Company's disclosure controls and procedures were not effective in ensuring that all material information relating to the Company required to be disclosed in this report has been made known to management in a timely manner and ensuring that this information is recorded, processed, summarized and reported within the time periods specified in the SEC's rules and regulations, because of the identification of a material weakness in our internal controls over financial reporting, identified below, which we view as an integral part of our disclosure controls and procedures.

 

-16-

 

(b) Changes in Internal Controls Over Financial Reporting

 

As previously reported, our annual assessment of the internal controls over financial reporting as of June 30, 2023 revealed a deficiency that we consider to be a material weakness: inadequate segregation of duties consistent with control objectives.

 

During fiscal 2024, the Company will continue to address changes needed to improve segregation of duties consistent with control objectives. We have added staff to grow sales. We expect that increased sales will enable us to add support staff, specifically in the accounting and shipping departments. A secondary effect of adding more staff will address needed improvements in segregation of duties consistent with control objectives.

 

PART II. OTHER INFORMATION

 

ITEM 5. OTHER INFORMATION

 

(A) Submission of Matters to a Vote of Security Holders

 

We held our annual meeting of shareholders for fiscal 2024 on Tuesday, November 14, 2023, at 4:00 p.m. EST. The following matters were considered and approved by the shareholders:

 

The following seven directors were elected to hold office for one-year terms or until their successors are elected and qualified:

 

 

   

Votes For

   

Votes Against

or Withheld

   

Non-Votes

   

Total Votes

 

Regina W. Anderson

    4,550,349       35,575       659,864       5,245,788  

James B. Anderson

    4,549,849       36,075       659,864       5,245,788  

Justice W. Anderson

    4,551,849       34,075       659,864       5,245,788  

Steven McComas

    4,552,016       35,575       659,864       5,247,455  

Monica L McCullough

    4,552,016       35,575       659,864       5,247,455  

Fred W. Suggs, Jr.

    4,552,016       35,575       659,864       5,247,455  

Joseph R. Treshler

    4,552,016       35,575       659,864       5,247,455  

 

-17-

 

 

Pursuant to the following vote, the appointment of Ferlita, Walsh, Gonzalez and Rodriguez, P.A. as our independent certified public accountants for the 2024 fiscal year, was ratified:

 

Votes For

   

Votes Against

   

Votes Abstaining

   

Total Votes

 
5,213,980      10,000      23,475      5,247,455  

 

ITEM 6. EXHIBITS

 

(A) EXHIBITS

 

//

10.1

Restated and Amended Executive Employment Agreement effective July1, 2023 between Justice W. Anderson, Procyon Corporation and AMERX Health Care Corporation.

//

10.2

Restated and Amended Executive Employment Agreement effective July1, 2023 between James B. Anderson, Procyon Corporation and AMERX Health Care Corporation.

//

10.3

Restated and Amended Executive Employment Agreement effective July1, 2023 between George O. Borak, Procyon Corporation and AMERX Health Care Corporation.

++

10.5

Business Line of Credit - Loan Agreement dated June 10, 2021

++

10.6

Business Line of Credit - Promissory Note dated June 10, 2021

**

10.7

Lease (164-166), effective January 15, 2021.

**

10.8

Lease (172), effective January 15, 2021.

 

31.1

Certification of Justice W. Anderson pursuant to Exchange Act Rule 13a-14(a)/15d-14(a)

 

31.2

Certification of James B. Anderson pursuant to Exchange Act Rule 13a-14(a)/15d-14(a)

 

32.1

Certification Pursuant to 18 U.S.C.§1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act Of 2002

  101.1* The following materials from the Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2023, formatted in iXBRL (Inline Extensible Business Reporting Language): (I) the Condensed Balance Sheets, (ii) the Condensed Consolidated Statements of Operations, (iii) the Consolidated Statements of Cash Flows, and (iv) the Notes to Condensed Consolidated Financial Statements
  104 Cover Page Interactive Data File (embedded within the Inline XBRL and contained in Exhibit 101)
  * Furnished, not filed
  // Incorporated by reference to the Company’s form 10-K filed on or about September 28, 2023.
  ++ Incorporated by reference to the Company’s form 10-K filed on or about October 28, 2021.
  ** Incorporated by reference to the Company’s form 8-K filed on or about January 27, 2021.

 

-18-

 

SIGNATURES

 

In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, there unto duly authorized.

 

 

PROCYON CORPORATION

 

November 22, 2023

By:/s/ JUSTICE W. ANDERSON

 

Date

Justice W. Anderson, Chief Executive Officer

 

 

-19-

 

Exhibit 31.1

 

CERTIFICATION

 

I, Justice W. Anderson, Chief Executive Officer of Procyon Corporation, certify that:

 

1.

I have reviewed this quarterly report on Form 10-Q of Procyon Corporation

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; and

 

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report.

 

4.

The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant issuer and have:

 

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

 

(b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

 

(c)

Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

 

(d)

Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

 

5.

The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

 

 

(a)

all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

 

 

(b)

any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

 

Date: November 22, 2023

 

/s/ JUSTICE W. ANDERSON

Justice W. Anderson, Chief Executive Officer

 

 

 

Exhibit 31.2

 

CERTIFICATION

 

I, James B. Anderson, Chief Financial Officer of Procyon Corporation, certify that:

 

1.

I have reviewed this quarterly report on Form 10-Q of Procyon Corporation

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to stated material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; and

 

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report.

 

4.

The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant issuer and have:

 

 

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

 

(b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

 

(c)

Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

 

(d)

Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

 

5.

The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

 

 

(a)

all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

 

 

(b)

any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

 

Date: November 22, 2023

/s/ JAMES B. ANDERSON

James B. Anderson, Chief Financial Officer

 

 

 

Exhibit 32.1

 

CERTIFICATION PURSUANT TO 18 U.S.C. §1350,

 

AS ADOPTED PURSUANT TO SECTION 906OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of Procyon Corporation (the "Company") on Form 10-Q for the period ended September 30, 2023, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), we, the undersigned Chief Executive Officer and Chief Financial Officer of the Company, do each certify, to our knowledge, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

 

(1)

The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

 

Dated: November 22, 2023

 

 

 

/s/ JUSTICE W. ANDERSON

/s/ JAMES B. ANDERSON

Justice W. Anderson Chief Executive Officer James B. Anderson, Chief Financial Officer

 

 
v3.23.3
Document And Entity Information - shares
3 Months Ended
Sep. 30, 2023
Nov. 14, 2023
Document Information [Line Items]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Sep. 30, 2023  
Document Transition Report false  
Entity File Number 0-17449  
Entity Registrant Name PROCYON CORPORATION  
Entity Incorporation, State or Country Code CO  
Entity Tax Identification Number 59-3280822  
Entity Address, Address Line One 164 Douglas Road East  
Entity Address, City or Town Oldsmar  
Entity Address, State or Province FL  
Entity Address, Postal Zip Code 34677  
City Area Code 727  
Local Phone Number 447-2998  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding (in shares)   8,108,388
Entity Central Index Key 0000812306  
Current Fiscal Year End Date --06-30  
Document Fiscal Year Focus 2024  
Document Fiscal Period Focus Q1  
Amendment Flag false  
v3.23.3
Consolidated Balance Sheets (Current Period Unaudited) - USD ($)
Sep. 30, 2023
Jun. 30, 2023
CURRENT ASSETS    
Cash $ 402,486 $ 451,306
Certificates of Deposit, plus accrued interest 566,602 562,472
Accounts Receivable, less allowance for credit losses of $18,370 and $11,625 respectively. 434,266 493,953
Inventories 544,267 431,405
Prepaid Expenses 215,724 298,469
TOTAL CURRENT ASSETS 2,163,345 2,237,605
PROPERTY AND EQUIPMENT, NET 315,273 281,023
OTHER ASSETS    
Deposits 4,665 9,220
Inventories 287,061 330,513
Intangible Asset 17,000 17,000
ROU Assets - Operating Leases 480,484 527,170
Deferred Tax Asset, Net of Valuation Allowance of $0 and $0, respectively 170,550 161,180
Assets, Noncurrent, Excluding Property, Plant and Equipment 959,760 1,045,083
TOTAL ASSETS 3,438,378 3,563,711
CURRENT LIABILITIES    
Accounts Payable 172,172 175,057
Accrued Expenses 220,904 277,498
Lease Liability, Current 175,317 173,565
TOTAL CURRENT LIABILITIES 568,393 626,120
LONG TERM LIABILITIES    
Lease Liability, Non-Current 275,410 319,882
TOTAL LONG TERM LIABILITIES 275,410 319,882
TOTAL LIABILITIES 843,803 946,002
Commitments and Contingencies  
STOCKHOLDERS' EQUITY    
Preferred Stock, 496,000,000 shares authorized, none issued. 0  
Common Stock, no par value, 80,000,000 shares authorized; 8,087,388 shares issued and outstanding. 4,450,166 4,444,766
Paid-in Capital 41,085 35,564
Accumulated Deficit (2,023,336) (1,989,481)
TOTAL STOCKHOLDERS' EQUITY 2,594,575 2,617,709
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY 3,438,378 3,563,711
Convertible Preferred Stock [Member]    
STOCKHOLDERS' EQUITY    
Preferred Stock, 496,000,000 shares authorized, none issued. $ 126,660 $ 126,860
v3.23.3
Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - USD ($)
$ / shares in Thousands
Sep. 30, 2023
Jun. 30, 2023
Accounts Receivable, Allowance for Credit Loss, Current $ 18,370 $ 11,625
Deferred Tax Assets, Valuation Allowance $ (0) $ 0
Preferred Stock, Shares Authorized (in shares) 496,000,000 496,000,000
Preferred Stock, Shares Issued (in shares) 0 0
Common Stock, No Par Value (in dollars per share) $ 0 $ 0
Common Stock, Shares Authorized (in shares) 80,000,000 80,000,000
Common Stock, Shares, Outstanding (in shares) 8,108,388 8,087,388
Common Stock, Shares, Issued (in shares) 8,108,388 8,087,388
Convertible Preferred Stock [Member]    
Preferred Stock, Shares Authorized (in shares) 4,000,000 4,000,000
Preferred Stock, Shares Issued (in shares) 166,900 167,100
Preferred Stock, No Par Value (in dollars per share) $ 0 $ 0
Preferred Stock, Shares Outstanding, Ending Balance (in shares) 166,900 167,100
v3.23.3
Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Sep. 30, 2023
Sep. 30, 2022
NET SALES $ 1,173,107 $ 1,175,703
COST OF SALES 260,705 294,904
GROSS PROFIT 912,402 880,799
OPERATING EXPENSES    
Salaries and Benefits 478,026 468,157
Selling, General and Administrative 491,767 424,095
Operating Costs and Expense 969,793 892,252
(LOSS) FROM OPERATIONS (57,391) (11,453)
OTHER INCOME    
Rental Income 8,958 0
Interest Income 5,208 895
Nonoperating Income (Expense) 14,166 895
(LOSS) BEFORE INCOME TAXES (43,225) (10,558)
INCOME TAX (EXPENSE) / BENEFIT 9,370 2,371
NET (LOSS) (33,855) (8,187)
Dividend requirements on preferred stock (3,633) (4,177)
Basic net (loss) available to common shares $ (37,488) $ (12,364)
Basic net (loss) per common share (in dollars per share) $ (0.01) $ (0)
Weighted average number of common shares outstanding (in shares) 8,108,388 8,087,388
Diluted net (loss) per common share (in dollars per share) $ (0.01) $ (0)
Weighted average number of common shares outstanding, diluted (in shares) 8,108,388 8,087,388
v3.23.3
Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)
Preferred Stock [Member]
Convertible Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balance (in shares) at Jun. 30, 2022 167,100 8,087,388      
Balance at Jun. 30, 2022 $ 126,860 $ 4,444,766 $ 35,564 $ (1,939,236) $ 2,667,954
Net Income (Loss) $ 0 $ 0 0 (8,187) (8,187)
Balance (in shares) at Sep. 30, 2022 167,100 8,087,388      
Balance at Sep. 30, 2022 $ 126,860 $ 4,444,766 35,564 (1,947,423) 2,659,767
Balance (in shares) at Jun. 30, 2023 167,100 8,087,388      
Balance at Jun. 30, 2023 $ 126,860 $ 4,444,766 35,564 (1,989,481) 2,617,709
Stock Based Compensation (in shares) 0 20,800      
Stock Based Compensation $ 0 $ 5,200 5,521 0 10,721
Preferred Stock Converted to Common (in shares) (200) 200      
Preferred Stock Converted to Common $ (200) $ 200      
Net Income (Loss) $ 0 $ 0 0 (33,855) (33,855)
Balance (in shares) at Sep. 30, 2023 166,900 8,108,388      
Balance at Sep. 30, 2023 $ 126,660 $ 4,450,166 $ 41,085 $ (2,023,336) $ 2,594,575
v3.23.3
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended
Sep. 30, 2023
Sep. 30, 2022
CASH FLOWS FROM OPERATING ACTIVITIES    
Net Income (Loss) $ (33,855) $ (8,187)
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation 19,154 10,913
Increase in Allowance for Doubtfull Accounts 6,745 0
Right of Use Asset Amortization 46,686 44,836
Accrued Interest on Certificates of Deposit (4,130) (173)
Deferred Income Taxes (9,370) 29,589
Valuation Allowance 0 (31,960)
us-gaap_ShareBasedCompensation 10,721 0
(Increase) Decrease in:    
Accounts Receivable 52,942 (120,077)
Deposits 4,555 1,445
Inventory (69,410) (13,143)
Prepaid Expenses 82,745 125,737
(Decrease) Increase in:    
Accounts Payable (2,885) (63,161)
Accrued Expenses (56,593) (104,714)
Payments on operating lease liability (42,720) (40,003)
NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES 4,585 (168,898)
CASH FLOW FROM INVESTING ACTIVITIES    
Purchase of property & equipment (53,405) (7,003)
NET CASH (USED IN) INVESTING ACTIVITIES (53,405) (7,003)
CASH FLOW FROM FINANCING ACTIVITIES    
NET CASH (USED IN) FINANCING ACTIVITIES 0 0
NET CHANGE IN CASH (48,820) (175,901)
CASH AT BEGINNING OF PERIOD 451,306 760,396
CASH AT END OF PERIOD 402,486 584,495
SUPPLEMENTAL DISCLOSURES    
Interest Paid 0 0
Taxes Paid $ 0 $ 0
v3.23.3
Note A - Summary of Accounting Policies
3 Months Ended
Sep. 30, 2023
Notes to Financial Statements  
Significant Accounting Policies [Text Block]

NOTE A - SUMMARY OF ACCOUNTING POLICIES

 

The interim consolidated financial statements included herein have been prepared by the Company without audit, pursuant to the rules and regulations of the Securities and Exchange Commission. Certain information and footnote disclosures normally included in the financial statements prepared in accordance with generally accepted accounting principles ("GAAP") have been condensed or omitted as allowed by such rules and regulations. The Company believes that the disclosures are adequate to make the information presented not misleading. These consolidated financial statements should be read in conjunction with the Company's audited consolidated financial statements dated June 30, 2023. The results for interim periods are not necessarily indicative of results that may be expected for any other interim period or for the full year.

 

Management of the Company has prepared the accompanying unaudited condensed consolidated financial statements prepared in conformity with generally accepted accounting principles, which require the use of management estimates, contain all adjustments (including normal recurring adjustments) necessary to present fairly the operations and cash flows for the period presented and to make the financial statements not misleading.

 

STOCK-BASED COMPENSATION

 

Stock based compensation is accounted for in accordance with Topic 718 - Compensation - Stock Compensation in the Accounting Standards Codification. Pursuant to Topic 718, all share-based payments to employees, including grants of employee stock options, are to be recognized in the statement of operations based upon their fair values. Topic 718 rescinds the acceptance of pro forma disclosure. In December 2009, our shareholders approved the adoption of a new stock option plan, providing the Company a continued means of offering stock-based compensation.

 

On September 30, 2023, there were 65,000 outstanding options to purchase shares of our common stock granted under our prior 2009 Stock Option Plan. There were 50,000 outstanding options to purchase shares of our common stock granted under our 2020 Stock Option Plan.

 

The fair value of a stock option is determined using the Black-Scholes option-pricing model, which values options based on the stock price at the grant date, the expected life of the option, the estimated volatility of the stock, the expected dividend payments, and the risk-free interest rate over the life of the option. There were 25,432 options granted during the quarter ended September 30, 2023.

 

The Black-Scholes option valuation model was developed for estimating the fair value of traded options that have no vesting restrictions and are fully transferable. Because option valuation models require the use of subjective assumptions, changes in these assumptions can materially affect the fair value of the options. Our options do not have the characteristics of traded options, therefore, the option valuation models do not necessarily provide a reliable measure of the fair value of our options.

 

 

Additional information with respect to stock option activity is as follows:

 

 

 

 

Number of

Shares

   

Weighted Average

Exercise Price

 

Outstanding at September 30, 2021

    115,00     $ 0.17  
Granted     -     $    
Exercised     -     $    
Cancelled     -     $    

Outstanding at September 30, 2022

    115,000     $ 0.17  
Granted     25,432     $ 0.25  
Exercised     -    

$

-  
Cancelled     -     $ -  

Outstanding at September 30, 2023

    140,432     $ 0.26  

Options exercisable at September 30, 2022

    115,000     $ 0.17  

Options exercisable at September 30, 2023

    140,432     $ 0.25  

 

EARNINGS PER SHARE

 

Basic earnings per share (EPS) is computed by dividing income available to common stockholders by the weighted-average number of common shares outstanding for the period. Diluted EPS reflects the potential dilution that would occur if dilutive securities such as stock options and other contracts to issue Common Stock were exercised or converted into Common Stock or resulted in the issuance of Common Stock that then shared in earnings. We use the treasury stock method to compute potential common shares from stock options and the as-if-converted method to compute potential common shares from Preferred Stock.

 

For the three months ended September 30, 2023, the potential dilutive effects of the preferred stock and stock options were excluded in the weighted-average shares outstanding, as the shares would have an anti-dilutive effect on the loss from operations.

 

For the three months ended September 30, 2022, the potential dilutive effects of the preferred stock and stock options were excluded in the weighted-average shares outstanding, as the shares would have an anti-dilutive effect on the loss from operations.

 

 

v3.23.3
Note B - Inventories
3 Months Ended
Sep. 30, 2023
Notes to Financial Statements  
Inventory Disclosure [Text Block]

NOTE B - INVENTORIES

 

 

Inventories consisted of the following:

 

  September 30,

2023

   

June 30,

2023

 
                 

Finished Goods

  $ 616,717     $ 576,548  

Raw Materials

    214,611       185,370  
    $ 831,328     $ 761,918  

 

At September 30, 2023 and June 30, 2023, respectively, $287,061 and $330,513 of our inventory was considered non-current as it will not be used within a one year period.

v3.23.3
Note C - Stockholders' Equity
3 Months Ended
Sep. 30, 2023
Notes to Financial Statements  
Equity [Text Block]

NOTE C - STOCKHOLDERS' EQUITY

 

During January 1995, the Company's Board of Directors authorized the issuance of up to 4,000,000 shares of Series A Cumulative Convertible Preferred Stock ("Series A Preferred Stock"). The preferred stockholders are entitled to receive, as and if declared by the board of directors, quarterly dividends at an annual rate of $.10 per share of Series A Preferred Stock per annum. Dividends will accrue without interest and will be cumulative from the date of issuance of the Series A Preferred Stock and will be payable quarterly in arrears in cash or publicly traded common stock when and if declared by the Board of Directors. As of September 30, 2023, no dividends have been declared. Dividends in arrears on the outstanding preferred shares total $441,569 as of September 30, 2023.

 

Holders of the Preferred Stock have the right to convert their shares of Preferred Stock into an equal number of shares of Common Stock of the Company. In addition, Preferred Stock holders have the right to vote the number of shares into which their shares are convertible into Common Stock. Such preferred shares will automatically convert into one share of Common Stock at the close of a public offering of Common Stock by the Company provided the Company receives gross proceeds of at least $1,000,000, and the initial offering price of the Common Stock sold in such offering is equal to or in excess of $1 per share. The Company is obligated to reserve an adequate number of shares of its common stock to satisfy the conversion of all the outstanding Series A Preferred Stock. There were 200 shares converted during the reporting period. So long as any share of Series A Preferred Stock is outstanding, the Company is prohibited from declaring dividends or other distributions related to its Common Stock or purchasing, redeeming or otherwise acquiring any of the Common Stock.

 

Share-based compensation expense recognized during the period is based on the value of the portion of share-based payment awards that is ultimately expected to vest. As share-based compensation expense recognized in the statement of operations is based on awards ultimately expected to vest, it can be reduced for estimated forfeitures. The ASC topic Stock Compensation requires forfeitures to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. The share based compensation charged against income for the periods ended September 30, 2023 and 2022 was $0 and $0 respectively.

 

 

The Black-Scholes option-pricing model, which values options based on the stock price at grant date, the expected life of the options, the estimated volatility of the stock and the risk free interest rate over the life of the option. The assumption used in the Black-Scholes model were as follows for the stock options granted in July 2023.

 

Stock Price at Date of Grant

  $ .248  

Risk-free interest rate

    3.97 %

Expected volatility of common stock

    90.37 %

Dividend yield

    0 %

Expected life of options (in years)

    10  

 

v3.23.3
Note D - Income Taxes and Available Carryforward
3 Months Ended
Sep. 30, 2023
Notes to Financial Statements  
Income Tax Disclosure [Text Block]

NOTE D - INCOME TAXES AND AVAILABLE CARRYFORWARD

 

As of September 30, 2023, the Company had consolidated income tax net operating loss ("NOL") carryforwards for federal income tax purposes of approximately $787,000. NOL arising before December 31, 2020 will expire in various years ending through the year 2035 and for losses arising in taxable years beginning after December 31, 2020, the deduction is limited to 80% of taxable income and can be carried forward indefinitely. The utilization of certain loss carryforwards are limited under Section 382 of the Internal Revenue Code.

 

The components of the provision for income tax (expense) attributable to continuing operations are as follows:

 

   

Three Months

   

Three Months

 
   

September 30, 2023

   

September 30, 2022

 
Current                

Federal

  $ 0     $ 0  

State

    0       0  
    $       $    

Deferred

               

Federal

  $ 7,764     $ 1,965  

State

    1,606       406  
    $ 9,370     $ 2,371  
                 

Total Income Tax Benefit / (Expense)

  $ 9,370     $ 2,371  

 

 

Deferred income taxes reflect the net tax effects of the temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of the Company's deferred tax assets and liabilities are as follows:

 

   

Non-Current

 

Deferred tax assets

       

NOL and contribution carryforwards

  $ 199,540  

Share based payments

    6,387  

Lease liabilities - operating leases

    114,237  

Accrued compensated absences

    10,271  

Accrued bonus

    1,465  

Allowance for doubtful accounts

    5,486  

Total deferred tax assets

    337,386  
         
Deferred tax (liabilities)        

Right-of-use-assets - operating leases

    (121,779 )

Excess of tax over book depreciation

    (45,057 )

Total deferred tax (liabilities)

    (166,836 )
         

Total deferred tax asset

    170,550  

Valuation Allowance

    -  

Net Deferred Tax Asset

  $ 170,550  
         
The change in the valuation allowance is as follows:        
June 30, 2023   $ 0  
September 30, 2023   $ -  
    $ 0  

 

Income taxes for the three months ended September 30, 2023 and 2022 differ from the amounts computed by applying the effective income tax rate of 25.35%, to income before income taxes as a result of the following:

 

   

Three Months

   

Three Months

 
   

September 30, 2023

   

September 30, 2022

 

Expected (provision) at US statutory rate

  $ 9,077     $ 2,217  

State income tax net of federal (provision)

    1,878       459  

Nondeductible Expense

    (1,539 )     (305 )

Change in estimates of loss carryforward

    (46 )     (31,960 )

Change in valuation allowance

    -     $ 31,960  

Income Tax (Expense)

  $ 9,370     $ 2,371  

 

 

The earliest tax year still subject to examination by a major taxing jurisdiction is fiscal year end June 30, 2021.

 

The Company performed a review of its uncertain tax positions in accordance with Accounting Standards Codification ASC 740-10 "Uncertainty in Income Taxes". In this regard, an uncertain tax position represents the Company's expected treatment of a tax position taken in a filed tax return, or planned to be taken in a future tax return, that has not been reflected in measuring income tax expense for financial reporting purposes.

v3.23.3
Note E - Line of Credit
3 Months Ended
Sep. 30, 2023
Notes to Financial Statements  
Debt Disclosure [Text Block]

NOTE E - LINE OF CREDIT

 

A line of credit was procured in June 2021, with a bank. The limit for this line of credit is $250,000. Terms of the line of credit include an interest rate that fluctuates based on prime plus a half of point, with monthly interest only payments. The line of credit renews annually on June 30th. This line of credit renews annually until either party decides otherwise. At September 30, 2023, the Company had drawn and owed $0 on the line of credit.

 

Interest expense for the year ended June 30, 2023 and the period ending September 30, 2023, was $0 and $0, respectively.

 

The line of credit is guaranteed by Justice W. Anderson, President and Chief Executive Officer.

v3.23.3
Note F - Recent Accounting Pronouncements
3 Months Ended
Sep. 30, 2023
Notes to Financial Statements  
Accounting Standards Update and Change in Accounting Principle [Text Block]

NOTE F - RECENT ACCOUNTING PRONOUNCEMENTS

 

Adoption of new accounting standards

 

New accounting standards or accounting standards updates were assessed and determined to be either not applicable or not having a material impact on the Company’s consolidated financial statements or processes.

v3.23.3
Note G - Right-of-use Assets and Lease Liabilities
3 Months Ended
Sep. 30, 2023
Notes to Financial Statements  
Lessee, Operating Leases [Text Block]

NOTE G - RIGHT-OF-USE ASSETS AND LEASE LIABILITIES

 

Operating leases

 

In August 2020, the Company entered into a lease agreement to lease certain office equipment with a lease term of 63 months. The lease renews on a month-to-month basis and contains an option to purchase the equipment at fair market value or return the equipment. Historically, the Company has not exercised the option to purchase at the end of the initial lease term for similar leases and simply returned the equipment at the end of the initial lease term. Initial rent amount was $574 per month. In applying ASC 842, the Company uses a lease term of 63 months and an incremental borrowing rate of 4.25% which was the borrowing rate on the Company’s line of credit with a financial institution.

 

In May 2021, the Company entered into a lease agreement to lease certain office equipment with a lease term of 39 months. The lease expires at the end of the lease term and the Company can simply return the equipment at the end of the initial lease term or upgrade the equipment during or at the end of the current lease term. Initial rent amount was $547 per month. In applying ASC 842, the Company uses a lease term of 39 months and an incremental borrowing rate of 4.25% which was the borrowing rate on the Company’s line of credit with a financial institution.

 

 

In January 2021, the Company entered in a lease agreement to lease warehouse space with a lease term of 64 months. The Company pays no rent for the first four months of the lease and pays $4,792.50 per month beginning the 5th month of the lease. Rent will increase each succeeding year by no less than 2% but not more than 5%. The rent amount includes common area maintenance charges which are considered nonlease components. In applying ASC 842, the Company is electing to account for nonlease components as being related to the lease component. In addition, the Company uses a lease term of 64 months and an incremental borrowing rate at prime rate of 3.25% which was the borrowing rate on the Company’s recent line of credit with a financial institution.

 

In January 2021, the Company entered in a lease agreement to lease office space with a lease term of 64 months. The Company paid no rent for the first four months of the lease and pays $9,372 per month beginning the 5th month of the lease. Rent will increase each succeeding year by no less than 2% but not more than 5%. The rent amount includes common area maintenance charges which are considered nonlease components. In applying ASC 842, the Company is electing to account for nonlease components as being related to the lease component. The Company also incurred initial direct cost of $114,083 related to existing improvements in the leased space. This initial direct cost has been included in determining the initial ROU asset and liability amounts. In addition, the Company uses a lease term of 64 months and an incremental borrowing rate at prime rate of 3.25% which was the borrowing rate on the Company’s recent line of credit with a financial institution.

 

The following is information related to the Company’s right-of-use assets and liabilities for its operating leases:

 

ROU assets - operating leases obtained in exchange for lease liabilities - operating leases   $ 979,744  
Amortization of ROU assets since lease inception   $ (499,260 )

ROU assets - operating leases at September 30, 2023

  $ 480,484  
         

Lease liabilities - operating leases on adoption date and increase in lease liabilities

  $ 979,744  

Payments on lease liabilities

    (529,017 )

Lease liabilities - operating leases on September 30, 2023

    450,727  

Lease liabilities - operating leases due in the 12 months ending September 30, 2024

    175,317  

Lease liabilities - operating leases due after September 30, 2024

  $ 275,410  

 

Variable lease expense was $50,567 and $50,020 for the three months ended September 30, 2023 and 2022, respectively.

 

Weighted average remaining lease term was 2.48 years and weighted average discount rate was 3.29% at September 30, 2023.

v3.23.3
Note H - Subsequent Events
3 Months Ended
Sep. 30, 2023
Notes to Financial Statements  
Subsequent Events [Text Block]

NOTE H - SUBSEQUENT EVENTS

 

We have evaluated subsequent events through November 15, 2023, which is the date the financial statements were available to be issued.

 

 

v3.23.3
Note A - Summary of Accounting Policies (Tables)
3 Months Ended
Sep. 30, 2023
Notes Tables  
Share-Based Payment Arrangement, Option, Activity [Table Text Block]

 

 

 

Number of

Shares

   

Weighted Average

Exercise Price

 

Outstanding at September 30, 2021

    115,00     $ 0.17  
Granted     -     $    
Exercised     -     $    
Cancelled     -     $    

Outstanding at September 30, 2022

    115,000     $ 0.17  
Granted     25,432     $ 0.25  
Exercised     -    

$

-  
Cancelled     -     $ -  

Outstanding at September 30, 2023

    140,432     $ 0.26  

Options exercisable at September 30, 2022

    115,000     $ 0.17  

Options exercisable at September 30, 2023

    140,432     $ 0.25  
v3.23.3
Note B - Inventories (Tables)
3 Months Ended
Sep. 30, 2023
Notes Tables  
Schedule of Inventory, Current and Noncurrent [Table Text Block]
Inventories consisted of the following:

 

  September 30,

2023

   

June 30,

2023

 
                 

Finished Goods

  $ 616,717     $ 576,548  

Raw Materials

    214,611       185,370  
    $ 831,328     $ 761,918  
v3.23.3
Note C - Stockholders' Equity (Tables)
3 Months Ended
Sep. 30, 2023
Notes Tables  
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]

Stock Price at Date of Grant

  $ .248  

Risk-free interest rate

    3.97 %

Expected volatility of common stock

    90.37 %

Dividend yield

    0 %

Expected life of options (in years)

    10  
v3.23.3
Note D - Income Taxes and Available Carryforward (Tables)
3 Months Ended
Sep. 30, 2023
Notes Tables  
Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]
   

Three Months

   

Three Months

 
   

September 30, 2023

   

September 30, 2022

 
Current                

Federal

  $ 0     $ 0  

State

    0       0  
    $       $    

Deferred

               

Federal

  $ 7,764     $ 1,965  

State

    1,606       406  
    $ 9,370     $ 2,371  
                 

Total Income Tax Benefit / (Expense)

  $ 9,370     $ 2,371  
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]
   

Non-Current

 

Deferred tax assets

       

NOL and contribution carryforwards

  $ 199,540  

Share based payments

    6,387  

Lease liabilities - operating leases

    114,237  

Accrued compensated absences

    10,271  

Accrued bonus

    1,465  

Allowance for doubtful accounts

    5,486  

Total deferred tax assets

    337,386  
         
Deferred tax (liabilities)        

Right-of-use-assets - operating leases

    (121,779 )

Excess of tax over book depreciation

    (45,057 )

Total deferred tax (liabilities)

    (166,836 )
         

Total deferred tax asset

    170,550  

Valuation Allowance

    -  

Net Deferred Tax Asset

  $ 170,550  
         
The change in the valuation allowance is as follows:        
June 30, 2023   $ 0  
September 30, 2023   $ -  
    $ 0  
Comprehensive Income (Loss) [Table Text Block]
   

Three Months

   

Three Months

 
   

September 30, 2023

   

September 30, 2022

 

Expected (provision) at US statutory rate

  $ 9,077     $ 2,217  

State income tax net of federal (provision)

    1,878       459  

Nondeductible Expense

    (1,539 )     (305 )

Change in estimates of loss carryforward

    (46 )     (31,960 )

Change in valuation allowance

    -     $ 31,960  

Income Tax (Expense)

  $ 9,370     $ 2,371  
v3.23.3
Note G - Right-of-use Assets and Lease Liabilities (Tables)
3 Months Ended
Sep. 30, 2023
Notes Tables  
Lessee, Operating Lease, Right-of-Use Assets and Liabilities [Table Text Block]
ROU assets - operating leases obtained in exchange for lease liabilities - operating leases   $ 979,744  
Amortization of ROU assets since lease inception   $ (499,260 )

ROU assets - operating leases at September 30, 2023

  $ 480,484  
         

Lease liabilities - operating leases on adoption date and increase in lease liabilities

  $ 979,744  

Payments on lease liabilities

    (529,017 )

Lease liabilities - operating leases on September 30, 2023

    450,727  

Lease liabilities - operating leases due in the 12 months ending September 30, 2024

    175,317  

Lease liabilities - operating leases due after September 30, 2024

  $ 275,410  
v3.23.3
Note A - Summary of Accounting Policies (Details Textual) - shares
3 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2021
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number 140,432 115,000 11,500
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares) 25,432 0  
The 2009 Option Plan [Member]      
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number 65,000    
The 2020 Option Plan [Member]      
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number 50,000    
v3.23.3
Note A - Summary of Significant Accounting Policies - Stock Options Activity (Details) - $ / shares
3 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2021
Outstanding at September 30, 2021 (in shares) 140,432 115,000 11,500
Outstanding at September 30, 2021 (in dollars per share) $ 0.26 $ 0.17 $ 0.17
Granted (in shares) 25,432 0  
Exercised (in shares) 0 0  
Cancelled (in shares) 0 0  
Granted (in dollars per share) $ 0.25    
Exercised (in dollars per share) 0    
Cancelled (in dollars per share) $ 0    
Options exercisable at September 30, 2022 (in shares) 140,432 115,000  
Options exercisable at September 30, 2022 (in dollars per share) $ 0.25 $ 0.17  
v3.23.3
Note B - Inventories (Details Textual) - USD ($)
Sep. 30, 2023
Jun. 30, 2023
Inventory, Noncurrent, Total $ 287,061 $ 330,513
v3.23.3
Note B - Inventories - Inventories (Details) - USD ($)
Sep. 30, 2023
Jun. 30, 2023
Finished Goods $ 616,717 $ 576,548
Raw Materials 214,611 185,370
Inventory, Gross $ 831,328 $ 761,918
v3.23.3
Note C - Stockholders' Equity (Details Textual) - USD ($)
1 Months Ended 3 Months Ended
Jan. 31, 2095
Sep. 30, 2023
Sep. 30, 2022
Jun. 30, 2023
Preferred Stock, Shares Authorized (in shares)   496,000,000   496,000,000
Share Price   $ 248    
Share-Based Payment Arrangement, Expense   $ 0 $ 0  
Minimum [Member]        
Proceeds From Public Offering Required for Mandatory Conversion   $ 1,000,000    
Share Price   $ 1    
Convertible Preferred Stock [Member]        
Preferred Stock, Shares Authorized (in shares) 4,000,000 4,000,000   4,000,000
Preferred Stock, Dividend Rate, Per-Dollar-Amount $ 0.1      
Dividends, Preferred Stock, Total   $ 0    
Preferred Stock, Amount of Preferred Dividends in Arrears   $ 441,569    
Convertible Preferred Stock, Shares Issued upon Conversion   1    
Conversion of Stock, Shares Converted (in shares)   200    
v3.23.3
Note C - Stockholders' Equity - Summary of Stock Option Valuation Assumptions (Details)
3 Months Ended
Sep. 30, 2023
$ / shares
Stock Price at Date of Grant (in dollars per share) $ 248
Risk-free interest rate 3.97%
Expected volatility of common stock 90.37%
Dividend yield 0.00%
Expected life of options (in years) (Year) 10 years
v3.23.3
Note D - Income Taxes and Available Carryforward (Details Textual) - USD ($)
3 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Operating Loss Carryforwards $ 787,000  
Effective Income Tax Rate Reconciliation, Percent, Total 25.35% 25.35%
v3.23.3
Note D - Income Taxes and Available Carryforward - Provision for Income Tax Expense (Details) - USD ($)
3 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Federal $ 0 $ 0
State 0 0
Federal 7,764 1,965
State 1,606 406
Deferred Federal, State and Local, Tax Expense (Benefit) 9,370 2,371
INCOME TAX (EXPENSE) / BENEFIT $ 9,370 $ 2,371
v3.23.3
Note D - Income Taxes and Available Carryforward - Deferred Tax Assets and Liabilities (Details) - USD ($)
3 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Jun. 30, 2023
NOL and contribution carryforwards $ 199,540    
Share based payments 6,387    
Lease liabilities - operating leases 114,237    
Accrued compensated absences 10,271    
Accrued bonus 1,465    
Allowance for doubtful accounts 5,486    
Total deferred tax assets 337,386    
Right-of-use-assets - operating leases (121,779)    
Excess of tax over book depreciation (45,057)    
Total deferred tax (liabilities) (166,836)    
Total deferred tax asset 170,550    
Valuation Allowance 0   $ 0
Net Deferred tax asset 170,550   161,180
Deferred Tax Assets, Valuation Allowance (0)   $ 0
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount $ (0) $ 31,960  
v3.23.3
Note D - Income Taxes and Available Carryforward - Income Taxes Reconciliation (Details) - USD ($)
3 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Expected (provision) at US statutory rate $ 9,077 $ 2,217
State income tax net of federal (provision) 1,878 459
Nondeductible Expense (1,539) (305)
Change in estimates of loss carryforward (46) (31,960)
Change in valuation allowance 0 31,960
Income Tax (Expense) $ 9,370 $ 2,371
v3.23.3
Note E - Line of Credit (Details Textual) - USD ($)
3 Months Ended 12 Months Ended
Sep. 30, 2023
Jun. 30, 2022
Jun. 30, 2021
Line of Credit Facility, Maximum Borrowing Capacity     $ 250,000
Long-Term Line of Credit $ 0    
Interest Expense, Debt $ 0 $ 0  
v3.23.3
Note G - Right-of-use Assets and Lease Liabilities (Details Textual) - USD ($)
1 Months Ended 3 Months Ended
May 31, 2021
Jan. 31, 2021
Aug. 31, 2020
Sep. 30, 2023
Sep. 30, 2022
Jun. 30, 2015
Variable Lease, Cost       $ 50,567 $ 50,020  
Operating Lease, Weighted Average Remaining Lease Term (Year)       2 years 5 months 23 days    
Operating Lease, Weighted Average Discount Rate, Percent       3.29%    
Operating Lease For Office Equipment [Member]            
Lessee, Operating Lease, Term of Contract 39 months         63 months
Lessee, Operating Lease, Rent Per Month $ 547   $ 574      
Lessee, Operating Lease, Discount Rate 4.25%   4.25%      
Operating Lease for Warehouse [Member]            
Lessee, Operating Lease, Term of Contract   64 months        
Lessee, Operating Lease, Discount Rate   3.25%        
Lessee, Operating Lease, Rent Per Month, First Four Months   $ 0        
Lessee, Operating Lease, Rent Per Month, Beginning After Fifth Month   $ 4,792        
Lessee, Operating Lease, Minimum Yearly Increase of Rent   2.00%        
Lessee, Operating Lease, Maximum Yearly Increase of Rent   5.00%        
Operating Lease for Office Space [Member]            
Lessee, Operating Lease, Term of Contract   64 months        
Lessee, Operating Lease, Discount Rate   3.25%        
Lessee, Operating Lease, Rent Per Month, First Four Months   $ 0        
Lessee, Operating Lease, Rent Per Month, Beginning After Fifth Month   $ 9,372        
Lessee, Operating Lease, Minimum Yearly Increase of Rent   2.00%        
Lessee, Operating Lease, Maximum Yearly Increase of Rent   5.00%        
Operating Lease, Initial Direct Cost Expense, over Term   $ 114,083        
v3.23.3
Note G - Right-of-use Assets and Lease Liabilities - Right-of-use Assets and Liabilities (Details) - USD ($)
3 Months Ended 15 Months Ended
Sep. 30, 2023
Sep. 30, 2023
Jun. 30, 2023
ROU assets - operating leases obtained in exchange for lease liabilities - operating leases $ 979,744    
Amortization of ROU assets since lease inception (499,260)    
ROU assets - operating leases at September 30, 2023 480,484 $ 480,484 $ 527,170
Lease liabilities - operating leases on adoption date and increase in lease liabilities   979,744  
Payments on lease liabilities   (529,017)  
Lease liabilities - operating leases on September 30, 2023 450,727 450,727  
Lease liabilities - operating leases due in the 12 months ending September 30, 2024 175,317 175,317 173,565
Lease liabilities - operating leases due after September 30, 2024 $ 275,410 $ 275,410 $ 319,882

Procyon (PK) (USOTC:PCYN)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Procyon (PK) Charts.
Procyon (PK) (USOTC:PCYN)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Procyon (PK) Charts.